From: Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites
Group | Total cases | CR | PR | SD | PD | Total effective rate |
---|---|---|---|---|---|---|
Observation group | 45 | 13 | 28 | 2 | 2 | 91.11% |
Control group | 35 | 2 | 12 | 16 | 5 | 40.00% |
χ2 | 25.79 | |||||
P value | P < 0.01 |